ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,359Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 189

$1.44M Total Retail Price of All Prescriptions

Rank: 1 out of 189

936 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 936 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 936 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 26,570 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
FUROSEMIDE 1,249 1,133 1 10
TRAZODONE HCL 1,241 1,122 2 16
WARFARIN SODIUM 1,208 1,046 3 14
LISINOPRIL 1,140 1,007 4 1
AMLODIPINE BESYLATE 886 857 5 4
LEVOTHYROXINE SODIUM 817 757 6 5
SERTRALINE HCL 765 717 7 17
SIMVASTATIN 726 650 8 2
METOPROLOL TARTRATE 706 634 9 6
ATENOLOL 590 556 10 12
OMEPRAZOLE 562 442 11 3
PRAVASTATIN SODIUM 493 418 12 13
GABAPENTIN 451 377 13 22
DONEPEZIL HCL 450 438 14 27
MIRTAZAPINE 430 415 15 45
ATORVASTATIN CALCIUM 429 381 16 9
HYDROCODONE-ACETAMINOPHEN 423 253 S3 17 11
CLOPIDOGREL 369 341 18 48
GLIPIZIDE 325 303 19 39
SPIRIVA 304 269 20 33
NAMENDA 294 284 21 49
CITALOPRAM HBR 269 203 22 15
HYDROCHLOROTHIAZIDE 263 248 23 8
ALLOPURINOL 247 234 24 25
ISOSORBIDE MONONITRATE ER 241 235 25 85
ENALAPRIL MALEATE 233 205 26 41
LOSARTAN POTASSIUM 232 210 27 20
METOPROLOL SUCCINATE 231 226 28 19
PLAVIX 228 212 29 74
LACTULOSE 210 201 30 93
CARBIDOPA-LEVODOPA 206 198 31 100
DIGOXIN 201 167 32 66
RISPERIDONE 198 194 33 82
METFORMIN HCL 195 172 34 7
PREDNISONE 193 177 35 38
LANTUS 183 158 36 56
TRAMADOL HCL 183 167 36 32
GLIPIZIDE ER 182 171 38 52
POTASSIUM CHLORIDE 181 179 39 61
CIPROFLOXACIN HCL 178 162 40 69
CYMBALTA 178 139 40 59
LOVASTATIN 176 152 42 21
RAMIPRIL 171 165 43 67
TAMSULOSIN HCL 169 169 44 28
OXYCONTIN 158 123 S2 45 75
ALENDRONATE SODIUM 157 145 46 18
ZOLPIDEM TARTRATE 156 117 47 24
PAROXETINE HCL 154 142 48 46
ADVAIR DISKUS 147 123 49 42
FLUOXETINE HCL 145 109 50 29
PROAIR HFA 141 104 51 35
TERAZOSIN HCL 139 126 52 89
NYSTATIN 133 123 53 159
CARVEDILOL 130 130 54 65
OXYCODONE HCL 129 114 S2 55 40
ESCITALOPRAM OXALATE 120 81 56 77
LEVETIRACETAM 115 114 57 119
CEPHALEXIN 114 106 58 138
HYDRALAZINE HCL 114 89 58 112
FINASTERIDE 112 99 60 83
PANTOPRAZOLE SODIUM 111 107 61 58
CRESTOR 110 97 62 31
PHENYTOIN SODIUM EXTENDED 107 57 63 145
AMITRIPTYLINE HCL 103 87 R 64 70
DILTIAZEM 24HR ER 103 78 64 68
DILTIAZEM 24HR CD 100 91 66 124
ISOSORBIDE DINITRATE 100 88 66 173
EXELON 99 99 68 101
VENLAFAXINE HCL ER 98 98 69 104
TRIAMTERENE-HCTZ 96 84 70 50
DIOVAN 94 91 71 51
NEXIUM 90 77 72 62
RANITIDINE HCL 90 73 72 26
IPRATROPIUM-ALBUTEROL 90 87 72 122
FAMOTIDINE 87 26 75 135
NOVOLOG FLEXPEN 86 86 76 178
BUPROPION HCL SR 86 59 76 113
PEN NEEDLE 85 66 78 144
DIVALPROEX SODIUM 83 65 79 99
OXYCODONE-ACETAMINOPHEN 83 73 S2 79 76
PRAMIPEXOLE DIHYDROCHLORIDE 82 82 81 179
AGGRENOX 81 69 82 180
METFORMIN HCL ER 79 60 83 37
JANUVIA 79 74 83 117
VERAPAMIL ER 78 76 85 72
SINGULAIR 78 75 85 107
CELEBREX 76 53 87 140
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 76 87 23
LEVOFLOXACIN 74 69 89 109
FLUTICASONE PROPIONATE 73 63 90 30
SPIRONOLACTONE 72 70 91 156
OLANZAPINE 70 55 92 136
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 51 92 123
TRICOR 69 50 94 106
MONTELUKAST SODIUM 67 58 95 134
LATANOPROST 67 67 95 128
LIDODERM 66 60 97 103
METOCLOPRAMIDE HCL 66 52 97 161
MORPHINE SULFATE ER 65 38 S2 99 137
QUETIAPINE FUMARATE 65 59 99 78
VENTOLIN HFA 65 32 99 157
BRIMONIDINE TARTRATE 64 51 102 190
IBUPROFEN 63 13 103 34
COLCRYS 62 62 104 163
SSD 61 58 105 195
SYMBICORT 61 43 105 165
OXYBUTYNIN CHLORIDE ER 61 61 105 130
MELOXICAM 61 61 105 54
LANTUS SOLOSTAR 60 48 109 170
LIPITOR 59 57 110 57
CYCLOBENZAPRINE HCL 59 33 R 110 90
GLIPIZIDE XL 58 45 112 97
NITROSTAT 57 55 113 205
ATENOLOL-CHLORTHALIDONE 57 57 113 87
KLOR-CON M20 57 50 113 80
NITROFURANTOIN MONO-MACRO 56 51 116 206
AMOXICILLIN 56 49 116 94
POLYETHYLENE GLYCOL 3350 56 25 116 64
LABETALOL HCL 56 56 116 163
ACTOS 53 48 120 132
ACETAMINOPHEN-CODEINE 53 17 S3 120 86
DOXAZOSIN MESYLATE 52 35 122 63
AZITHROMYCIN 51 44 123 47
ALPRAZOLAM 51 42 123 95
AMOX TR-POTASSIUM CLAVULANATE 50 46 125 147
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.